Evidence map›Paper›PMID 31175699›Full record

ArticleCancer science2019

Clinicopathological significance of heterogeneic ezrin expression in poorly differentiated clusters of colorectal cancers.

Akane Aikawa, Hideto Fujita, Takeo Kosaka, Hiroshi Minato, Etsuko Kiyokawa

Open access · goldAbstract read
In one paragraph

Article in Cancer science, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.9field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Pathophysiological Roles of Actin-Binding Scaffold Protein, Ezrin.International journal of molecular sciences · 2022
    Review
  3. Review
  4. Article
  5. Article
  6. Ezrin Mediates Invasion and Metastasis in Tumorigenesis: A Review.Frontiers in cell and developmental biology · 2020
    Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Akane AikawaDepartment of Oncologic Pathology, Kanazawa Medical University, Kahoku-gun, Japan.ORCID https://orcid.org/0000-0001-5709-1968
Hideto FujitaDepartment of Surgery, Kanazawa Medical University, Kahoku-gun, Japan.
Takeo KosakaDepartment of Surgery, Kanazawa Medical University, Kahoku-gun, Japan.
Hiroshi MinatoDepartment of Diagnostic Pathology, Ishikawa Prefectural Central Hospital, Kanazawa, Japan.
Etsuko KiyokawaDepartment of Oncologic Pathology, Kanazawa Medical University, Kahoku-gun, Japan.ORCID https://orcid.org/0000-0002-0326-0479
Kanazawa Medical University · JPIshikawa Prefectural Central Hospital · JP

Funding

Japan Society for the Promotion of Science 17K08774Kanazawa Medical University K2016-12Kanazawa Medical University S2015-15
6 · The paper itself

Abstract

Multicellular structures, such as tumor buddings and poorly differentiated clusters (PDC), exist at the invasive front of colorectal cancers (CRC). Although it has been reported that CRC with PDC showed frequent lymph node metastases with a worse prognosis, the molecular markers of PDC that are responsible for prognosis have not been identified. We here noticed for the first time that Ezrin, a regulator of the actin cytoskeleton, is expressed in the corner cells of PDC. We then aimed to verify whether heterogeneous Ezrin expression in PDC predicts the prognosis of CRC patients. We immunohistochemically analyzed Ezrin expression in PDC of 184 patients with completely resected stages I-III CRC. We established the Ezrin corner score (ECS), which quantifies the tendency of Ezrin-positive cells to accumulate at the corners of PDC. On the basis of ECS values, 2 indices, the mean ECS and the number of PDC with high ECS, were obtained. Both indices were significantly higher in CRC with lymphatic invasion, higher PDC grade, and presence of micropapillary (MP) PDC. The mean ECS-high group showed shorter recurrence-free survival than the mean ECS-low group but without significance. The other index, the number of ECS-high PDC, was significantly associated with recurrence-free survival. These results suggest that Ezrin is involved in PDC progression and lymphatic invasion, and that ECS may be a marker for aggressive PDC.

Indexed as

AdultAgedAged, 80 and overBiomarkers, TumorCell DifferentiationColorectal NeoplasmsCytoskeletal ProteinsDisease-Free SurvivalDisease ProgressionEzrinFemaleHumansLymphatic MetastasisMaleMiddle AgedNeoplasm Recurrence, LocalBiomarkers, TumorCytoskeletal ProteinsEzrincolorectal cancerEzrinmicropapillarypoorly differentiated clustersprognosis

Identifiers

PMID31175699
PMCPMC6676292
OpenAlexW2954965269

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.